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Malnutrition, hypoxia and energy deficit may aect protein metabolism. We wanted to evaluate the cross-sectional
association between serum amino acids and fat-free mass in a group of hypoxic patients. We also wanted to explore,
in the same group of patients, whether the blood amino-acid pattern could possibly be influenced by dierences in
lung function and energy intake. Serum amino acids were measured in 71 hypoxic underweight and normal-weight
patients with advanced pulmonary disease and related to the fat-free-mass index, arterial oxygen (PaO2) and carbon
dioxide tension (PaCO2), forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1) and energy intake.
Only one amino acid (aspartic acid) remained significantly correlated to the fat-free-mass index after adjustments
for age and sex (b=70?30, P=0?011). None of the amino acids were significantly correlated to PaO2 but alanine
was significantly negatively correlated to PaCO2 (b=70?46, P50?001), phenylalanine to FVC1 (b=0?52, P=0?001)
and tyrosine to FVC (b=0?36, P=0?008). Citrulline and tryphtophane were significantly correlated to energy
intake (b=0?32, P=0?008; b=0?37, P=0?009 respectively). In conclusion, there was no convincing association
between fat free mass and serum amino acids. The negative eect of hypercapnia and reduced lung function on
some serum amino acids was suggested and some amino acids were sensitive to reduced energy intake.
Key words: pulmonary disease; serum amino acids; nutritional status; lung function; energy intake.
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Severe chronic obstructive pulmonary disease (COPD) is
frequently associated with weight loss which involves both
a reduction in fat mass and the wasting of the fat-free mass
(FFM) (1). The loss of FFM can occur as part of being
underweight, but it can also occur in normal-weight
patients who may suer from physical impairment and
reduced respiratory muscle strength to an even greater
degree than the underweight patients with relatively well-
preserved FFM (1–2).
Plasma free amino acid concentrations express the
balance between exogenous uptake and intercurrent meta-
bolites in protein synthesis and breakdown, which are
influenced by hormonal factors, the availability of vitamins
and cofactors, and pathological states (3).
In previous studies of plasma amino acids, changes have
been found in malnourished patients compared withReceived 7 March 2000 and accepted 19 March 2000.
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0954-6111/00/090868+07 $35?00/0healthy controls (4–7). Hypoxia has been shown experi-
mentally to inhibit protein synthesis in animals (8) and to
increase the net loss of amino acids from skeletal muscle in
man (9). Underweight patients may have a negative energy
balance, which may contribute to gluconeogenesis and the
depression of protein synthesis (10). We wanted to
investigate whether there were dierences in blood amino
acids in relation to dierences in fat-free mass in a group of
hypoxic patients. We also wanted to explore in the same
group of patients whether the blood amino-acid pattern
could possibly be influenced by dierences in lung function
and energy intake.
Patients and methods
PATIENTS
The participants were 71 consecutive underweight and
normal-weight, severely incapacitated patients, with end-
stage pulmonary disease who were referred to the Depart-
ment of Thoracic Medicine and assessed for lung trans-
plantation between August 1993 and August 1998. The# 2000 HARCOURT PUBLISHERS LTD
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transplantation were applied (11). In underweight and
normal-weight patients respectively, the majority had
COPD (n=24 and n=16), while other diagnoses were
COPD with a-1 antitrypsin deficiency (n=5 and n=1),
fibrosing alveolitis (n=4 and n=7), sarcoidosis (n=2 and
n=4), bronchiectasis (n=4 and n=0) and lymphangioleio-
myelomatosis (n=3 and n=1). The study was approved by
the regional ethics committee.
STUDY DESIGN
This was a cross-sectional study with the time span for
inclusion set at 5 years. The patients were referred to the
hospital from all over Norway to be evaluated for lung
transplantation. Rikshospitalet is the only hospital in the
country which performs organ transplantation. The
patients were contacted by telephone in their homes by a
dietitian 3–4 weeks prior to their admission to hospital.
After obtaining the patient’s informed consent, a scale and
a booklet for recording food were mailed to the patient.
Measurements were performed after the patients arrived at
the hospital. The use of prednisolone was recorded from the
hospital files.
NUTRITIONAL ASSESSMENT
Anthropometry
Body height was measured to the nearest 1?0 cm with the
subject standing without shoes. Body weight was measured
to the nearest 0?2 kg with the subjects wearing light clothing
and no shoes. The weight of the clothes (1 kg) was
subtracted. The body mass index (BMI) was calculated as
the ratio of the body weight to the height squared and
expressed in kgm72. Patients with a BMI below of 19, or
between 19 and 25 with a weight loss greater than 10%
from their usual weight, were defined as underweight and,
when the BMI was between 19 and 25 and the weight loss
was equal to or less than 10%, they were defined as normal-
weight. The mid-arm circumference (MAC) of the left arm
was measured with non-elastic tape. Skinfolds were
measured with a Harpeden skinfold caliper. The mean of
three readings was used. All the measurements were
performed by the same investigator. The mid-arm muscle
circumference (MAMC) was calculated from the triceps
skinfold (TSF) and MAC: MAMC (cm)=MAC (cm)
73?14*TSF (cm). The TSF and MAMC values measured
in our study were compared with standard values for age
and sex from a Swedish study comprising almost 2000
subjects (12) and the data were expressed as a percentage of
the mean. The fat mass (FM) was estimated subcutaneously
from the sum of the skinfold thickness at four sites;
bicipital, tricipital, subscapular and suprailiac using the
Durnin tables (13). The fat-free mass (FFM) was assessed
by subtracting the FM from body weight. The fat-free-mass
index (FFMI) was computed by dividing the FFM by the
height squared.Dietary assessment
The patients recorded their food intake for 7 consecutive
days prior to hospital admission. During the visit to the
clinic, the same dietitian reviewed the records with the
patients to ensure completeness. Patients who were
accepted for pre-lung transplant assessment at short notice
and were not contacted before admission were asked to
participate in the study after arriving at hospital. They were
interviewed by the same trained dietitian about their food
habits using the dietary-history methods with a cross-check
(14). The eating pattern during the preceding 3 weeks was
defined as the usual eating pattern.
Blood samples
Venous blood samples were taken by the hospital sta after
the patients had fasted overnight. Concentrations of
creatinine, urea, alanin aminotransferase (ALAT), aspartic
aminotransferase (ASAT), alkaline phosphatase (ALP) and
C-reactive protein (CRP) in serum were analysed using
routine laboratory methods at the Clinical Chemistry
Department, Rikshospitalet. Pre-albumin was measured
with antiserum in an immunochemical reaction measured
using nephelometry on a Behring Nephelometer 2 (Dade
Behring, Marburg, Germany). The sample for amino acids
was immediately cooled and analysed within 1 h one milli
liter of serum was deproteinized with 30mg of sulphosa-
licylic acid, mixed thoroughly and centrifuged at 48C for
10min. To 100ml of the supernatant 100ml of Biotronik
dilution buer was added. The amino acids were separated
on a Biotronik LC 5001 (Eppendorf Biotronik, Maintal,
Germany) using liquid chromatography with SCX columns
and five dierent lithium-based buers with increasing pH
and ion strength. Post-column the amino acid concentra-
tions were measured photometrically at 440 nm and 570 nm
after being mixed with ninhydrin. (Our laboratory partici-
pates in a European quality assurance programme for the
analysis of amino acids as a member of the ERNDIM
Foundation, European Research Network for evaluation
and improvement of screening, diagnosis and treatment of
Inherited Disorders of Metabolism.) The mean coecient
of variance (between-day CV) for all amino acids is about
5%. Tryptophane deviates from the mean (CV 16%).
PULMONARY FUNCTION TESTS
Dynamic lung volumes, forced vital capacity (FCV) and
forced expiratory volume in 1 sec (FEV1) were measured
using an automated pulmonary function unit (Gould 2400,
Sensormedics, Bilthoven, the Netherlands). The reference
values were those recommended by the European Respira-
tory Society (15).
Arterial blood samples were obtained from the radial
artery for measurements of arterial O2(PaO2), arterial
CO2(PaCO2) tension and arterial O2 saturation, with the
patients resting and breathing room air. They were
analysed on a Ciba Corning Blood Gas Analyser 845
(Bayer, Sudbury, England).
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The data were analysed using the SPSS program (SPSS for
Windows, Release 9?0?0, SPSS Inc., Chicago, IL, U.S.A.
1998). The intake of nutrients was calculated using the
Fiber computer program and the Norwegian food compo-
sition table (16). Parametric and non-parametric tests were
chosen as appropriate and mean and median values were
given accordingly. An independent-samples t-test or Wil-
coxon’s rank sum test was used to compare groups.
Correlations were made using Pearson’s correlation coe-
cient or Spearman’s correlation coecient to test the
associations between the serum amino acid and FFMI
and lung functions and total energy intake. Multiple
regressions with the amino acid as the dependent factor
were performed to adjust for age and sex. A two-way
ANOVA was used to test whether dierent dietary
assessment methods influenced the energy intake in the
underweight patients compared with normal-weight ones.
Since many correlations were calculated, a significance level
of P0?01 was regarded as significant (instead of the usual
P0?05).
Results
The anthropometric measurements are shown in Table 1.
There were no significant dierences between the under-
weight and normal-weight patients in terms of lung
function. The mean for the whole group was for FVC 48
(95%CI 44–52)% predicted, FEV1 24 (95%CI 21–28)%
predicted, PaO2 7?3 (95%CIC 7?0–7?7) kPa, PaCO2 6?4
(95%CI 6?0–6?7) kPa and pH 7?44 (95%CI 7?38–7?50).
Long-term oxygen treatment was being used by 86% of
underweight and 79% normal-weight patients. Oral main-
tenance medication with corticosteroids was being used by
48% of the underweight patients and 79% of the normal-TABLE 1. Anthropometric measurements in underweight and no
Underweight
Mean (95%CI)
n 42
Male/female 20/22
Age (years) 47 (25–60)
Weight (kg) 50?5* (48?1–52?8)
Height (cm) 170 (168–173)
BMI (kgm72) 17?3* (16?7–17?8)
TSF (%) 54* (47–61)
MAMC (%) 84* (80–87)
FFMI (kgm72) 14?4* (13?9–14?8)
Definition of abbreviations—BMI: body mass index; TSF (%)
muscle circumference per cent of standard; FFMI: fat-free mas
{Mean (range), *P50?001, independent-samples t-test.weight ones with a median dose of 0mg and 7?5mg
respectively.
Twenty-eight patients kept a food record and 12 kept a
dietary history in the underweight group with correspond-
ing figures in the normal-weight group being 24 for food
records and five for dietary history. Two dietary assess-
ments were not available in the underweight patients. In the
remaining underweight and normal-weight patients the
intake of energy was 8?1 and 7?5 MJ, protein 66 and 70 g,
fat 39 and 37 and carbohydrates 215 and 205 g respectively.
To check for the potential influence of dierent dietary
assessment methods on energy intake, we performed a two-
way ANOVA with dietary method and group as factors
and ln (energy intake) as the dependent variable. This
analysis confirmed that there was no significant dierence
between the underweight patients and those of normal
weight. Serum measurements for liver and renal functions
and acute-phase-reaction protein were within the normal
range (Table 2). Amino-acid measurements were not
available for two patients; one underweight and one
normal-weight. There were no significant dierences for
serum amino acids in the underweight patients compared
with the normal-weight ones (Table 3). Only one amino
acid (aspartic acid) remained significantly correlated to
FFMI after adjustments for age and sex (Table 4). None of
the amino acids was significantly correlated to PaO2, but
alanine was negatively correlated to PaCO2 and phenylala-
nine/tyrosine was positively correlated to FEV1 (Table 4).
Citrulline and tryptophane were positively correlated to
energy intake (Table 5). The use of corticosteroids (mg
prednisolone or years used) did not correlate to any of the
amino-acid levels.
Discussion
Disturbances in plasma amino acids have been found in
depleted patients with COPD compared with healthyrmal-weight patients
Normal-weight
Mean (95%CI)
29
12/17
52 (26–60)
64?5 (61?3–67?7)
170 (167–173)
22?2 (21?6–22?8)
96 (82–110)
97 (94–101)
15?7 (15?1–16?3)
triceps skinfold per cent of standard; MAMC (%): mid-arm
s index
TABLE 2. Serum levels of prealbumin, creatinine, urea, ALAT, ASAT and CRP in underweight and normal-weight patients
Underweight Normal-weight
Mean (95%CI) Mean (95%CI)
Prealbumin (g l71) 0?22 (0?20–0?24) 0?24 (0?20–0?24)
Creatinine (mmol l71) 70 (67–74) 75 (70–81)
Urea (mmol l71) 4?0 (3?6–4?4) 4?4 (3?9–4?9)
ALAT (U/L*) 18 18
ASAT (U/L*) 170 17
ALP (U/L*) 162 147
CRP (mg l71*) 12 7
ALAT: Alanin aminotransferase; ASAT: aspartic aminotransferase; ALP: alkaline phosphatase; CRP: C-reactive
protein.*Median.
TABLE 3. Mean serum amino acid concentrations, mmol l71 (95% CI) in 41 underweight patients and 28 normal-weight
patients
Amino acids Underweight Normal-weight
Taurine 129 (116–141) 125 (109–140)
Phosphoethanolamine* 0 0
Aspartic acid 17 (14–19) 15 (12–17)
Hydroxyproline* 2 2
Threonine 116 (102–131) 112 (101–123)
Serine 124 (115–134) 114 (105–123)
Asparagine 43 (36–49) 43 (34–52)
Glutamic acid 48 (41–55) 44 (38–51)
Glutamine 616 (572–661) 590 (559–621)
Proline 135 (121–149) 131 (112–150)
Glycine 246 (226–266) 220 (203–236)
Alanine 270 (224–295) 274 (246–303)
Citrulline 26 (22–30) 24 (19–29)
a–aminobutyric acid 9 (7–11) 12 (10–14)
Valine 189 (176–202) 199 (181–217)
Cystine 26 (22–30) 33 (26–40)
Methionine 20 (18–22) 20 (18–22)
Isoleucine 50 (45–55) 49 (43–55)
Leucine 100 (90–109) 102 (92–112)
Tyrosine 56 (51–61) 62 (55–69)
Phenylalanine 58 (54–62) 58 (55–61)
Homocystine* 0 0
Tryptophane 38 (32–44) 38 (32–44)
Ornithine 64 (55–74) 70 (56–83)
Lysine 156 (133–180) 155 (127–184)
Histidine 70 (64–77) 69 (63–75)
1–Methistidine* 1 7
3–Methylistidine* 0 0
Arginine 109 (98–119) 104 (95–114)
Branched–chain amino acids 338 (313–363) 350 (317–382)
Branched/aromatic amino acids 2?3 (2?1–2?4) 2?2 (2?1–2?4)
Essential amino acids 726 (677–776) 733 (684–783)
Total amino acids 2748 (2589–2907) 2706 (2568–2843)
*Median
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TABLE 4. Serum amino acids that significantly correlated to FFMI and parameters of lung functions
Crude Adjusted*
Amino acids (mmol l71) r P b P
Aspartic acid FFMI (kgm72) 70?30 0?00 70?36 0?01
Valine FFMI (kgm72) 0?32 0?01 0?19 0?16
Isoleucine FFMI (kgm72) 0?33 0?01 0?17 0?17
SumEAA FFMI (kgm72) 0?32 0?01 0?21 0?11
BCAA FFMI (kgm72) 0?33 0?01 0?17 0?19
FVC (l) 0?36 0?00 0?28 0?03
Leucine FVC (l) 0?33 0?01 0?24 0?06
Tyrosine FVC (l) 0?36 0?00 0?35 0?00
FEV1 (l) 0?31 0?01 0?31 0?01
Phenylalanine FVC (l) 0?30 0?01 0?27 0?02
FEV1 (l) 0?52 0?00 0?51 0?00
Alanine PaCO2 (kPa) 70?46 0?00 70?48 0?00
FFMI: Fat-free-mass index; EAA: essential amino acids; BCAA: branched-chian amino acids; FVC: forced vital capacity;
FEV1: forced expiratory volume in 1 sec; PaCO2: arterial carbon dioxide tension. *All adjusted or age and sex, for FVC and
FEV1 and for height.
TABLE 5. Serum amino acids (mmol l71) that siginificantly
correlated to intake of energy (kJ)
Crude Adjusted*
Amino acids r P b P
Glutamine 0?35 0?00 0?27 0?04
Citrulline 0?32 0?01 0?35 0?01
Leucine 0?34 0?01 0?21 0?10
Tryptophane 0?37 0?00 0?34 0?01
*Adjusted for age and sex.
872 L. FØRLI ET AL.controls who diered from patients with regard to both
nutritional status and lung function (4–7). Since hypoxia
has been shown to interfere with protein metabolism (8–9),
the disturbances in plasma amino acids in patients might
have been influenced by decreased lung function. We
therefore wanted to see whether the blood amino-acid
pattern diered in a group of hypoxic patients in
accordance with the dierence in fat-free mass. We found
no convincing association between fat-free mass and serum
amino acids as only one amino acid remained significantly
correlated to the fat-free-mass index after adjustments for
age and sex. We also wanted to explore whether decreased
lung function measured by blood gases and spirometry
could be related to serum amino acids. The most striking
findings were the positive correlation between phenylalnine
and FEV1 and the negative correlation between alanine and
PaCO2. Phenylalanine and tyrosine are interrelated. The
body can convert phenylalanine to tyrosine, but not viceversa, so the former is the dietary essential (17). Changes in
tyrosine and phenylalanine metabolism have already been
shown in malnourished patients with COPD (5,7). An
elevated tyrosine eux from the legs and decreased protein
synthesis have been shown in emphysematous patients
compared with healthy controls (7). The plasma phenyla-
laine concentration was lower in the patients than in the
healthy control subjects. Schols et al. found reduced
concentrations of both tyrosine and phenylalanine in the
venous blood of patients compared with healthy controls
(5). Our results suggest that reduced FEV1 and FVC might
have a negative influence on the concentrations of
phenylalanine and tyrosine in venous blood.
None of the amino acids was significantly correlated to
PaO2. This could be due to the fact that most patients were
hypoxic or else it could be partly due to oxygen treatment.
Improved skeletal muscle metabolism has been shown in
hypoxic patients with COPD after long-term oxygen
therapy (18).
PaCO2, which is a good indicator of the severity of
respiratory failure, was significantly negatively correlated to
alanine. Alanine is an important glucogenic amino acid.
The unique role of alanine in amino-acid exchange has led
to the formulation of the glucose-alanine cycle which
involves gluconeogenesis in the liver, followed by the
transport of glucose to a peripheral tissue where either
alanine or lactate is released as the end product of glycolysis
(19). Consequently, ATP is formed in the peripheral tissue.
Several studies have shown disturbances in muscle energy
metabolism in patients with COPD (20–23). Jakobsen et al.
found indications of an augmented glycolytic and a reduced
aerobic capacity (21). Another study has shown a low
concentration of ATP in the muscles of COPD patients
with acute exacerbations with marked hypoxaemia, hyper-
capnia and acidosis (20).
SERUM AMINO ACIDS AND ADVANCED PULMONARY DISEASE 873Many of our patients were underweight and may have
had a negative energy balance. The intake of protein in our
patients was quite high, 1?4 g kg71 body weight in the
underweight patients and 1?1 g kg71 in the normal-weight
ones. Patients with a negative energy balance and adequate
protein intake would use protein for energy supply (10).
Elevated norepinephrine levels have been measured in
patients with advanced emphysema (6), which could
indicate an increased need for gluconeogensis (24).
Although we did not observe any relationship between
the use of glucocorticosteroids and the serum levels of
amino acids, they are known to stimulate gluconeogenesis
and to do so in synergy with norepinephrine.
Previous studies which examined amino-acid levels in
arterial blood (4,7) and venous blood (5,6) in patients with
pulmonary disease were performed in patients groups
which diered in composition from those in our study.
They were mostly older than those in our study and
depleted patients were generally compared with healthy
controls. Three of these studies reported reduced plasma
alanine, glutamine and glutamic acid concentrations (4,5,7),
whereas Hoord et al. found normal plasma amino-acid
levels except for increased glutamine and aspartic acid (6).
In view of the findings in our study, the dierences in
plasma alanine when compared with healthy controls could
possibly be due to dierences in lung function rather than
dierences in nutritional status. Schols et al. found
decreased venous levels of glutamine and tryptophane
which were independent of depletion (5). This could agree
with our findings, at least in the case of tryptophane, which
was related to the intake of energy but not to nutritional
status.
In conclusion, the main findings in our study that there
was little or no association between serum amino acids and
fat-free mass. Our results further suggest some negative
influence by hypercapnia and reduced lung function on
some amino acids. Finally, some amino acids may be
sensitive to a reduced intake of energy.
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